The increased expression of this factor has been studied to influence the glioma cells’ invasion, migration and proliferation activity, whereas its insufficient expression has an inhibitory effect on NF-κB signaling pathway [64]. The gene discussed is NFKB1; the disease is central nervous system cancer.